Articles

Two medtech companies can look identical on paper— • Same clinical data • Same FDA pathway • Same market size …and have completely different outcomes. The difference is rarely the technology. It’s how much behavior change is required for adoption. At a certain point, you’re not underwriting product adoption— you’re underwriting system change. And system change behaves very differently: • timelines extend • capital requirements increase • forecasts become unreliable Yet

If you are experiencing any of the below, resist the temptation: 1. High commercial pressure + fewer resources Smaller companies often operate with: Limited sales forces Investors demanding rapid revenue growth Narrow product pipelines (one or two products) This can create pressure to “stretch” marketing claims to drive adoption, especially if the approved indication is narrow. But: Pressure does not reduce legal risk, it only increases temptation. 2. Misunderstanding of the

For CEOs, founders, and entrepreneurs seeking to raise capital, the focus is often on one thing: securing the funds needed to fuel...

In healthcare, the most impactful commercial strategies don’t start with a product—they start with a problem. Many organizations still...

In private equity, growth and value creation hinge on one key factor: leadership. No matter how promising the business or how innovative...

Here's Where Companies Go Wrong Too often, companies in search of a new CEO don’t present an accurate picture of their true condition....

In times of uncertainty, whether driven by economic shifts, global crises, or market disruptions, businesses face unique challenges that...

As businesses evolve from their early stages to maturity, they often experience stagnation in growth. While this is a common phenomenon,...

Engaging with the wrong sales distributor can severely impede the commercial success of your medical products. For both startups and...

Medical device commercial teams can fail for a variety of reasons, many of which are linked to strategic missteps, poor alignment with...

Entering the U.S. medical device market is a dream for many companies—but the reality can be much more complex than anticipated. It’s...